Hello, everyone, and nice to see you again. Hope your weekend was relaxing. Now, of course, the time has come to resume the routine of meetings and deadlines. So please join us as we prepare that mandatory cup of stimulation, or perhaps you fancy a bottle of water. Whatever your pleasure, here are a few items to help jumpstart your day. Best of luck and stay in touch...
Vertex Licenses Hepatitis C Compounds (Mass High Tech)
Amgen Sr VP Of Research David Lacey Will Retire (San Francisco Business Times)
Pfizer Defends Viagra Patent In Court This Week (Dow Jones)
Glaxo And Valeant Epilepsy Pill Is Approved By The FDA (Dow Jones)
Merck Redesigns Drug Labels To Cut Dispensing Errors (Associated Press)
FDA Urges Drugmakers To Provide Advance Warning Of Shortages (Pharma Times)
AstraZeneca Loses Nexium Patent Ruling In Europe (Bloomberg News)
Harbin Pharma Apology For Pollution Fails To Quell Anger (People's Daily)
UK Participation In Clinical Trials Declines (Pharma Times)
South Africa Procurement Laws Welcomed By Local Pharma (Business Day)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr